344 filings
Page 4 of 18
8-K
zpop r3gsmj2xh
14 Aug 19
Departure of Directors or Certain Officers
4:37pm
8-K
i56ix0iz ehzhpr2l0x
17 Jul 19
Seelos Therapeutics Announces Investigational New Drug Application Submission for SLS-005
9:07am
8-K
n8bb3trh3267g4hm3t9l
27 Jun 19
Validated, Pre-Clinical Success Shown in Modifying the Regulation of the SNCA Gene Which Encodes Alpha-Synuclein Expression
7:24am
8-K
4g0f39hw
17 Jun 19
Entry into a Material Definitive Agreement
9:55pm
8-K
cyeraz6n59jl
21 May 19
Seelos Therapeutics Reports Q1 2019 Pipeline Update
2:40pm
8-K
m22f6grk
13 May 19
Departure of Directors or Certain Officers
5:02pm
8-K
h8ybg hxn3y53
8 Apr 19
Changes in Registrant's Certifying Accountant
4:15pm
8-K
2nt5v97 cxzdi6r7
26 Mar 19
Departure of Directors or Certain Officers
4:55pm
8-K
hg6 zvq5v9b3
8 Mar 19
Entry into a Material Definitive Agreement
6:39am
8-K/A
c6k 28dwwm1gts7snhw
1 Mar 19
Departure of Directors or Certain Officers
4:19pm
8-K
11i9vzirmi87pkdbr
19 Feb 19
Seelos Therapeutics Completes Acquisition of Trehalose from Bioblast Pharma
8:00am
8-K
8hgfi6 voa
6 Feb 19
Entry into a Material Definitive Agreement
4:15pm
8-K/A
rkcw8
30 Jan 19
Financial Statements and Exhibits
4:15pm
8-K
ujp3hl85ssf41f1
24 Jan 19
Other Events
8:06am
8-K
fv634p
24 Jan 19
Completion of Acquisition or Disposition of Assets
8:05am
8-K
hsywhu a8q0
16 Jan 19
Entry into a Material Definitive Agreement
12:00am
8-K
anw0phq
4 Jan 19
Entry into a Material Definitive Agreement
5:22pm
8-K
lb173p0lmicckmv1nade
14 Dec 18
Entry into a Material Definitive Agreement
4:48pm
8-K
9qii880
16 Nov 18
Entry into a Material Definitive Agreement
4:15pm
8-K
qs40ec
31 Oct 18
Apricus Biosciences Provides Corporate Update and Third Quarter 2018 Financial Results
4:34pm